Alkermes plc.
Current role
ALKS
Craig Hopkinson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Craig Hopkinson
The proxy statement of Alkermes plc. reports total compensation of $3,617,908 for Craig Hopkinson in fiscal 2025, including a base salary of $764,837. Disclosed compensation is on record for 8 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Alkermes plc. (ALKS)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alkermes plc.
Other people whose current roles at this company are on record from its filings.
- Blair C. Jackson CEO, CFO, COO
- Mr. Richard F. Pops CEO
- Iain M. Brown CFO, Chief Accounting Officer
- Blair Jackson COO
- James A. Robinson COO
- Samuel J. Parisi Chief Accounting Officer
- Andy Wilson Board Member
- Anne C. Whitaker Board Member
- Brian McKeon Board Member
- Brian P. McKeon Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $764,837 | $3,617,908 |
| 2024 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $742,560 | $4,343,991 |
| 2023 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $714,000 | $4,226,388 |
| 2022 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $693,000 | $4,546,920 |
| 2021 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $670,000 | $4,727,478 |
| 2020 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $650,000 | $3,957,135 |
| 2019 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $621,000 | $3,656,337 |
| 2018 | Alkermes plc. (ALKS) | Executive Vice President, Research and Development and Chief Medical Officer | $600,000 | $3,791,198 |
Recent activity
No call appearances or filed executive changes recorded yet.